Universal driving restrictions beyond 4 weeks appear unnecessary following CAR-T therapy in multiple myeloma

Overview of attention for article published in Blood Advances, May 2025

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

news: 1 news outlet
twitter: 17 X users

bluesky: 4 Bluesky users

Readers on

mendeley: 4 Mendeley

So far, Altmetric has seen 6 Bluesky posts from 4 Bluesky users, with an upper bound of 3,605 followers.

RP @yleyfman.bsky.social: New study in Blood Advances led by Rahul Banerjee & Gurbakhash Kaur challenges the 8-week driving restriction for patients receiving CAR-T therapy for multiple myeloma (MM). Researchers analyzed 586 patients and found that only…

RP @yleyfman.bsky.social: @rahulbanerjeemd.bsky.social @fredhutch.bsky.social @mountsinainyc.bsky.social @mountsinai.bsky.social ashpublications.org/bloodadvance...

This page shows the most recent Bluesky posts that mention this research output. Click here to find out how to access more activity, including 2 additional Bluesky posts.